Mir-17–92 regulates bone marrow homing of plasma cells and production of immunoglobulin G2c

The polycistronic mir-17–92 cluster, also known as oncomir-1 , was previously shown to be essential for early B lymphopoiesis. However, its role in late-stage B-cell differentiation and function remains unexplored. Here we ablate mir-17–92 in mature B cells and demonstrate that mir-17–92 is dispensa...

Full description

Saved in:
Bibliographic Details
Published inNature communications Vol. 6; no. 1; p. 6764
Main Authors Xu, Shengli, Ou, Xijun, Huo, Jianxin, Lim, Kristen, Huang, Yuhan, Chee, Sheena, Lam, Kong-Peng
Format Journal Article
LanguageEnglish
Published London Nature Publishing Group UK 17.04.2015
Nature Publishing Group
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The polycistronic mir-17–92 cluster, also known as oncomir-1 , was previously shown to be essential for early B lymphopoiesis. However, its role in late-stage B-cell differentiation and function remains unexplored. Here we ablate mir-17–92 in mature B cells and demonstrate that mir-17–92 is dispensable for conventional B-cell development in the periphery. Interestingly, mir-17–92 -deficiency in B cells leads to enhanced homing of plasma cells to the bone marrow during T-cell-dependent immune response and selectively impairs IgG2c production. Mechanistically, mir-17–92 directly represses the expression of Sphingosine 1-phosphate receptor 1 and transcription factor IKAROS, which are, respectively, important for plasma cell homing and IgG2c production. We further show that deletion of mir-17–92 could reduce IgG2c anti-DNA autoantibody production and hence mitigate immune complex glomerulonephritis in Shp1-deficient mice prone to autoimmunity. Our results identify important roles for mir-17–92 in the regulation of peripheral B-cell function. After activation and selection, plasma cells home to the bone marrow where they persist and continue to make antibodies. Here the authors show that the mir-17–92 cluster coordinates the process by regulating the homing receptor S1PR1 and the transcription factor IKAROS that controls IgG2c production.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:2041-1723
2041-1723
DOI:10.1038/ncomms7764